It has been weeks since Martin Shkreli promised to lower the price of Daraprim, but apparently that might have been a lie just to stop the outrage.
How long does it take to lower the price of a drug (especially when there are people whose lives depend on it)? Well, the NY Times article that revealed that Shkreli had raised the price of Daraprim by 50 times — a 30 day supply of the drug still costs over $27,000 — revealed a similar price hike on by another company on cycloserine, a tuberculosis drug. The price of that drug was lowered the next day.
Meanwhile, Shkreli’s company has had time to hire four lobbyists. I guess that was more important.